Antigens for pre-erythrocytic malaria vaccines: building on success. - Wikidata - awgldk - TriplyDB

Antigens for pre-erythrocytic malaria vaccines: building on success.

Antigens for pre-erythrocytic malaria vaccines: building on success.

http://www.wikidata.org/entity/Q37582431

about

CD8+ T cells specific for a malaria cytoplasmic antigen form clusters around infected hepatocytes and are protective at the liver stage of infection.Plasmodium Helical Interspersed Subtelomeric (PHIST) Proteins, at the Center of Host Cell Remodeling.Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites Humoral immune responses to Plasmodium falciparum among HIV-1-infected Kenyan adults Metabolomic analysis of patient plasma yields evidence of plant-like α-linolenic acid metabolism in Plasmodium falciparum Pre-erythrocytic malaria vaccines: identifying the targets.Profiling the Targets of Protective CD8+ T Cell Responses to Infection.TAP-mediated processing of exoerythrocytic antigens is essential for protection induced with radiation-attenuated Plasmodium sporozoites.

P2860

Q30555356-39D7902F-7349-496F-996B-13E5E27DAD52 Q34539136-8230394D-7F5B-4C0E-8BA9-663BFE04977B Q35051549-1EE3E203-8AAD-454A-8C90-22AEEE361574 Q36123104-0C497EC6-EA83-464D-8AA3-9A0C8348B405 Q36376191-CFFAE94D-CD2A-4965-8964-9F2426F18624 Q36644236-9163381C-3E4B-4FE7-9133-D5224A667F7D Q41693606-2C715E12-276D-4C34-A32C-4677E6DAE66F Q47941316-AA0A0338-04EB-4169-A1D8-54F6CC32FCDB

P2860

Antigens for pre-erythrocytic malaria vaccines: building on success.

http://www.wikidata.org/entity/Q37582431

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Antigens for pre-erythrocytic malaria vaccines: building on success.

@en

Antigens for pre-erythrocytic malaria vaccines: building on success.

@nl

type

label

Antigens for pre-erythrocytic malaria vaccines: building on success.

@en

Antigens for pre-erythrocytic malaria vaccines: building on success.

@nl

prefLabel

Antigens for pre-erythrocytic malaria vaccines: building on success.

@en

Antigens for pre-erythrocytic malaria vaccines: building on success.

@nl

P1433

Q37582431-2F1C86EB-CC07-46B8-A58D-681D2EF1FBED

P1476

Q37582431-DC6ABA54-860B-4ED5-844B-617B50216317

P2093

Q37582431-0B081313-E714-4895-9D88-EBDB8E81B3C3

Q37582431-E7D496FB-9781-4CA1-9D29-8BED434479D3

P2860

Q37582431-0292FE8E-8500-4DF7-AD2E-B44779DD28D4

Q37582431-034D3B19-ACDF-4CD9-A03E-8BC5B86AC8F0

Q37582431-0436FA58-C2B8-4BFB-BBA6-24E4779E6384

Q37582431-0B6ED860-365D-4EAD-828F-42AD3660BB8A

Q37582431-117C33A1-3517-4328-997D-4A129D3BB947

Q37582431-1373B02F-295C-4A88-B16A-574A857A6A78

Q37582431-149897AE-01A0-45E4-BF5B-991DB569E261

Q37582431-178CA5E2-A209-4AA6-A8B7-08557BB1CAC5

Q37582431-1CF21603-E607-4FC0-B069-7388393A9C17

Q37582431-1DEDA8F2-0F42-4152-B97B-42B93025D6CF

P304

Q37582431-CE1838BB-5BAE-4F8D-9B81-7F8F3EFD226F

P31

Q37582431-72248496-BFDF-4159-8800-8B12A30D7135

P356

Q37582431-34411E7E-E99A-408A-AFBE-CCF260862D21

P433

Q37582431-CDADF9F2-4A9A-450E-9DE9-FF2A52BF0228

P478

Q37582431-29BE958B-5089-4556-918F-E6349DAF8219

P577

Q37582431-B772F7FB-F4E5-42A1-B71A-7AF469E35911

P5875

Q37582431-841FA560-8E63-44D6-BFC8-03683F5EEC06

P698

Q37582431-2FF0B701-84C9-4833-921E-D135B7D8209D

P921

Q37582431-0E660CEA-7976-4D71-9C5B-140267BED2D7

P932

Q37582431-9E958907-21E0-452B-A4FC-9BB6F25AB5E7

P356

J.1365-3024.2009.01139.X

P1433

Parasite Immunology

P1476

Antigens for pre-erythrocytic malaria vaccines: building on success.

@en

P2093

C Speake

http://www.w3.org/2001/XMLSchema#string

P E Duffy

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative genomics of the neglected human malaria parasite Plasmodium vivax

The genome of the simian and human malaria parasite Plasmodium knowlesi

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

Genome sequence of the human malaria parasite Plasmodium falciparum

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei

A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

P304

539-546

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-3024.2009.01139.X

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26752304

http://www.w3.org/2001/XMLSchema#string

P698

19691557

http://www.w3.org/2001/XMLSchema#string

P921

P932

4112517

http://www.w3.org/2001/XMLSchema#string